31791419|t|Circadian sleep/wake-associated cells show dipeptide repeat protein aggregates in C9orf72-related ALS and FTLD cases.
31791419|a|Motor-, behavior- and/or cognition-related symptoms are key hallmarks in patients with amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) with TDP-43 pathology (FTLD-TDP), respectively. It has been reported that these patients also experience sleep disturbances, which might implicate a disturbed circadian rhythm of the sleep/wake cycle. It remains unknown, however, whether cells involved in the circadian sleep/wake cycle are affected by ALS- and FTLD-related neuropathological changes including phosphorylated TDP-43 (pTDP-43) aggregates and dipeptide repeat protein (DPR) inclusions resulting from the C9orf72 hexanucleotide repeat expansion. Immunohistochemistry for DPR and pTDP-43 pathology was performed in post-mortem hypothalamus and pineal gland tissue of patients with ALS and/or FTLD-TDP with and without the C9orf72 repeat expansion and healthy controls. Circadian sleep/wake-associated cells, including pinealocytes and hypothalamic neurons related to the suprachiasmatic nucleus (SCN), were microscopically assessed. We observed numerous DPR inclusions (poly(GA), poly(GP), poly(GR) and poly(PR)) in the pinealocytes and few poly(GA) inclusions in the SCN-related neurons in C9orf72-related ALS and/or FTLD-TDP cases. These circadian sleep/wake-associated cells, however, were devoid of pTDP-43 pathology both in C9orf72- and nonC9orf72-related ALS and/or FTLD-TDP cases. Our neuropathological findings show that pinealocytes and, to a lesser extent, SCN-related neurons are affected by DPR pathology. This may reflect an involvement of these cells in sleep/wake disturbances observed in ALS and/or FTLD-TDP patients.
31791419	82	89	C9orf72	Gene	203228
31791419	98	101	ALS	Disease	MESH:D000690
31791419	106	110	FTLD	Disease	MESH:D057174
31791419	191	199	patients	Species	9606
31791419	205	234	amyotrophic lateral sclerosis	Disease	MESH:D000690
31791419	236	239	ALS	Disease	MESH:D000690
31791419	245	278	frontotemporal lobar degeneration	Disease	MESH:D057174
31791419	280	284	FTLD	Disease	MESH:D057174
31791419	291	297	TDP-43	Gene	23435
31791419	309	317	FTLD-TDP	Disease	MESH:D057174
31791419	366	374	patients	Species	9606
31791419	391	409	sleep disturbances	Disease	MESH:D012893
31791419	589	592	ALS	Disease	MESH:D000690
31791419	598	602	FTLD	Disease	MESH:D057174
31791419	662	668	TDP-43	Gene	23435
31791419	755	762	C9orf72	Gene	203228
31791419	916	924	patients	Species	9606
31791419	930	933	ALS	Disease	MESH:D000690
31791419	941	949	FTLD-TDP	Disease	MESH:D057174
31791419	971	978	C9orf72	Gene	203228
31791419	1229	1237	poly(GP)	Chemical	-
31791419	1239	1247	poly(GR)	Chemical	-
31791419	1252	1260	poly(PR)	Chemical	-
31791419	1340	1347	C9orf72	Gene	203228
31791419	1356	1359	ALS	Disease	MESH:D000690
31791419	1367	1375	FTLD-TDP	Disease	MESH:D057174
31791419	1478	1485	C9orf72	Gene	203228
31791419	1510	1513	ALS	Disease	MESH:D000690
31791419	1521	1529	FTLD-TDP	Disease	MESH:D057174
31791419	1717	1740	sleep/wake disturbances	Disease	MESH:D012893
31791419	1753	1756	ALS	Disease	MESH:D000690
31791419	1764	1772	FTLD-TDP	Disease	MESH:D057174
31791419	1773	1781	patients	Species	9606
31791419	Association	MESH:D000690	203228
31791419	Association	MESH:D057174	203228
31791419	Association	MESH:D057174	23435

